Generated by GPT-5-mini| Liver | |
|---|---|
![]() Tvanbr · Public domain · source | |
| Name | Liver |
| Latin | Hepar |
| Caption | Human liver (anterior view) |
| System | Digestive system |
| Location | Right upper quadrant of abdomen |
| Arteries | Hepatic artery proper |
| Veins | Hepatic veins, portal vein |
| Nerves | Hepatic plexus |
| Precursor | Endoderm |
Liver
The liver is a large visceral organ situated in the right upper quadrant of the abdomen that performs diverse synthetic, metabolic, detoxification, and immunologic tasks. It receives dual blood supply from the portal vein and hepatic artery and is central to systemic homeostasis, interacting with organs such as the Pancreas, Gallbladder, Small intestine, Spleen, and Kidney. The organ’s structure and cell types underpin functions described in clinical, surgical, and research contexts across institutions like Mayo Clinic, Johns Hopkins Hospital, and Cleveland Clinic.
Macroscopic anatomy includes the right and left lobes separated by the falciform ligament and the functional division into hepatic segments defined by the Couinaud classification used in Hepatic lobectomy planning at centers such as Mount Sinai Health System. The organ’s external landmarks include the porta hepatis where the portal triad (portal vein, hepatic artery, bile duct) enters, and the caudate and quadrate lobes recognized during procedures at Massachusetts General Hospital. Microscopically, hepatic lobules contain plates of hepatocytes arranged around a central vein, with portal triads at corners; sinusoidal endothelial cells, Kupffer cells, and hepatic stellate cells contribute to architecture studied at universities like Harvard University and Stanford University.
Vascular anatomy: dual inflow from the portal vein (≈75% of blood, nutrient-rich) and hepatic artery (≈25% oxygen-rich) and outflow via hepatic veins to the Inferior vena cava—an arrangement critical in portal hypertension management by teams at University College London Hospitals. Biliary anatomy includes intrahepatic bile ducts converging to the common hepatic duct, the cystic duct from the gallbladder, and the common bile duct entering the duodenum near the ampulla of Vater, a focus of endoscopic therapy at Mayo Clinic and Cleveland Clinic.
Primary functions include synthesis of plasma proteins (e.g., albumin, clotting factors II, VII, IX, X), storage of glycogen and fat-soluble vitamins (A, D, E, K), and bile production for lipid digestion coordinated with the Duodenum. The organ performs detoxification via cytochrome P450 enzymes (CYPs) influencing drug metabolism studied at UCSF Medical Center and University of Cambridge. Immune functions involve Kupffer cells clearing pathogens and immune complexes, interacting with immune organs such as the Spleen and Thymus in systemic responses examined at National Institutes of Health.
Regulation of glucose and lipid homeostasis links the organ to endocrine organs including the Pancreas (insulin/glucagon) and the Adrenal cortex (corticosteroids) in metabolic disease research at centers like Imperial College London. The organ also synthesizes angiotensinogen affecting the Renin–angiotensin system and participates in heme catabolism producing bilirubin processed with assistance from the Gallbladder and excreted into the Duodenum.
Central metabolic pathways include gluconeogenesis, glycogenolysis, glycolysis, and the urea cycle; enzymes such as carbamoyl phosphate synthetase I and ornithine transcarbamylase are essential and implicated in inherited disorders treated at Great Ormond Street Hospital. Lipid metabolism involves hepatic synthesis of cholesterol and lipoproteins (VLDL, HDL) regulated by nuclear receptors like PPARα and SREBP, areas of pharmacologic targeting by companies like Pfizer and AstraZeneca. Phase I and II biotransformation reactions mediated by CYP450 isoforms and conjugation enzymes (UGT, GST) modulate xenobiotic clearance, central to toxicology studied at Centers for Disease Control and Prevention.
Bile acid synthesis from cholesterol via CYP7A1 and enterohepatic circulation with the Ileum coordinate fat absorption; disruptions underlie cholestatic diseases managed by specialists at Royal Free Hospital. Iron metabolism involves ferritin storage and hepcidin production regulating systemic iron handled in clinical studies at University of Oxford.
Embryologically, the organ arises from foregut endoderm with signaling pathways (FGF, BMP, Wnt, Notch) driving hepatic specification studied in developmental biology programs at MIT and Columbia University. Hepatic progenitors differentiate into hepatocytes and cholangiocytes; abnormalities cause congenital malformations addressed in pediatric centers like Children's Hospital of Philadelphia. Unique regenerative capacity after partial hepatectomy involves hepatocyte proliferation, cytokines (IL-6, TNF-α), and growth factors (HGF), a process investigated in regenerative medicine at Wake Forest Institute for Regenerative Medicine.
Chronic injury activates hepatic stellate cells leading to fibrosis and cirrhosis via extracellular matrix deposition; antifibrotic strategies are under investigation in trials sponsored by organizations such as World Health Organization and European Medicines Agency.
Common conditions include viral hepatitis (hepatitis A, hepatitis B, hepatitis C) with epidemiology studied by World Health Organization and Centers for Disease Control and Prevention; alcoholic liver disease linked to patterns studied by WHO and National Institute on Alcohol Abuse and Alcoholism; and nonalcoholic fatty liver disease associated with metabolic syndrome explored at American Heart Association. Genetic disorders include hemochromatosis (HFE mutations), Wilson disease (ATP7B), and alpha-1 antitrypsin deficiency, with management guidelines from bodies like European Association for the Study of the Liver.
Neoplasms include hepatocellular carcinoma and cholangiocarcinoma, with staging and treatment protocols developed at oncology centers such as MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Vascular and biliary complications include portal hypertension, variceal bleeding addressed by techniques from ASGE and hepatic encephalopathy linked to ammonia metabolism.
Diagnostic modalities include liver function tests (ALT, AST, ALP, bilirubin), imaging (ultrasound, CT, MRI), elastography for fibrosis assessment, and histology from percutaneous or transjugular biopsy performed in tertiary centers like Guy's and St Thomas' NHS Foundation Trust. Serologic testing for viral hepatitides is guided by protocols from CDC and WHO.
Treatment spans lifestyle modification, antiviral therapy (direct-acting antivirals for hepatitis C developed by pharmaceutical collaborations involving Gilead Sciences), immunization for hepatitis B recommended by WHO, pharmacotherapy for metabolic disease using agents from Novartis and Bristol-Myers Squibb, and targeted oncology treatments including loco-regional therapies (TACE, radiofrequency ablation) practiced at MD Anderson Cancer Center.
Surgical interventions include partial hepatectomy, living-donor and deceased-donor transplantation coordinated by transplant programs at UCLA Health, University of Pittsburgh Medical Center, and Hammersmith Hospital; perioperative care addresses coagulopathy, portal flow, and immunosuppression with agents from companies like Roche. Interventional radiology provides portal vein embolization and TIPS creation for portal hypertension at centers such as Karolinska University Hospital.
Prognostic scoring systems (Child–Pugh, MELD) guide prioritization for transplantation and resource allocation in systems used by UNOS and national transplant registries. Multidisciplinary management involves hepatology, surgery, oncology, radiology, and pathology groups at comprehensive centers including Cleveland Clinic, Johns Hopkins Hospital, and Imperial College Healthcare NHS Trust.
Category:Human anatomy